The Biden Administration proposes limits on short-term health insurance plans. The Food and Drug Administration grants full approval to an experimental Alzheimer’s disease treatment. And, healthcare costs are expected to rise 7 percent next year, according to a new report. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
